Silence Therapeutics SLN
NASDAQ SLN
$19.77 -0.02 (-0.08%)
As of: Nov 11, 2026 · 11:44 AM EST

Silence Therapeutics (SLN) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Silence Therapeutics (SLN) recorded Depreciation & Amortization (CF) of $73,000 in the quarter ended Jun 30, 2026, down 9.9% from $81,000 a year earlier but up 1.4% from the prior quarter.

Analysis

Silence Therapeutics (SLN) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a TTM basis, Silence Therapeutics' Depreciation & Amortization (CF) came in at $303,000 as of Jun 30, 2026, down 4.1% year-over-year; for the year ended Dec 31, 2025, it was $312,000, down 7.1% from the prior year.

  • Annual Depreciation & Amortization (CF) has declined for three straight years, with a five-year compound annual growth rate of -12.6% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $336,000 in the year ended Dec 31, 2024 (-41.4%), $573,412 in the year ended Dec 31, 2023 (-3.1%), $591,577 in the year ended Dec 31, 2022 (+4.6%) and $565,486 in the year ended Dec 31, 2021 (-7.5%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $72,000 in the quarter ended Mar 31, 2026 to $88,000 in the quarter ended Mar 31, 2024 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in 1 of the last six quarters, with an average decline of 6.4%.
  • Per Business Quant, the preceding three quarters came in at $72,000 (quarter ended Mar 31, 2026), $77,000 (quarter ended Dec 31, 2025) and $81,000 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Silence Therapeutics 935.01 Mn 862.91 Mn - 73,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 73,000.00
Mar 31, 2026 72,000.00
Dec 31, 2025 77,000.00
Sep 30, 2025 81,000.00
Jun 30, 2025 81,000.00
Mar 31, 2025 73,000.00
Dec 31, 2024 76,000.00
Sep 30, 2024 86,000.00
Jun 30, 2024 86,000.00
Mar 31, 2024 88,000.00
Dec 31, 2023 139,009.01
Sep 30, 2023 146,935.44
Jun 30, 2023 145,158.13
Mar 31, 2023 143,430.12
Dec 31, 2022 165,382.89
Sep 30, 2022 133,175.96
Jun 30, 2022 141,043.19
Mar 31, 2022 150,285.60
Dec 31, 2021 86,272.68
Sep 30, 2021 146,129.84
API Access

Silence Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SLN&period=max&api_key=YOUR_API_KEY